Silverback Therapeutics

Stealth mode immuno-oncology biotech startup

placeSeattle, Washington, United States calendar_todayFounded 2016 groups17 employees language silverbacktx.com

Registered entities

Investor mix

18 investors on record; lead investors include USVP, Orbimed, EcoR1; 1 has since exited.

Investor typeCountShare
Venture capital739%
Private equity422%
Other / undisclosed739%
Coming soon